Close
Nordic 9Nordic 9

Ochre Bio (private company)

United Kingdom ochre-bio.com
See something wrong or missing? Let us know
Offices:London
Industry:BiotechHealth services
Business model:B2B

Ochre Bio is a British biotech company developing RNA medicines for chronic liver diseases by using deep phenotyping (‘phenomics’) in order to digitize liver biology at scale, from healthy through to advanced liver disease.

Investors: we tracked 20 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 39.75M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Ochre Bio

Name Criteria
Germany Atai Life Sciences
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 11
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
United Kingdom Sano Genetics
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 4
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Netherlands Leyden Labs
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Mogrify
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom bit.bio
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 4
  • At least one vc investor: found 3
  • At least one other investor: found 5
  • Total raised in a similar range: 10M+ USD
United Kingdom Synthace
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 6
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Italy Kither Biotech
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 5
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Belgium eTheRNA
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 4
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Germany Resolve BioSciences
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top